Quick Answer
REGENTIS BIOMATERIALS LTD. reported Stockholders Equity of $4.74 million for fiscal year 2025.
REGENTIS BIOMATERIALS LTD. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.74M | +111.5% |
| 2024 | -$41.10M | +10.5% |
| 2023 | -$45.91M | -9.1% |
| 2022 | -$42.06M | — |
- REGENTIS BIOMATERIALS LTD. showed an increase of +111.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, REGENTIS BIOMATERIALS LTD.’s stockholders equity has grown by 111.3% (from -$42.06 million to $4.74 million).
- The most recent figure is from REGENTIS BIOMATERIALS LTD.’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: